What Does This Test Measure?
Thyroid peroxidase (TPO) antibodies are autoantibodies directed against thyroid peroxidase, an enzyme critical for thyroid hormone synthesis. Elevated TPO antibodies are the hallmark of autoimmune thyroid disease, specifically Hashimoto thyroiditis, and are present in ~90% of cases. They are also present in ~50–80% of Graves disease cases.
<35 IU/mL = negative (varies by lab assay; some labs use <9 IU/mL). Low-level positivity (35–100) is common and may not indicate active disease. Strongly positive (>100–200 IU/mL) is associated with autoimmune thyroid disease.
Why Your Doctor Ordered This Test
TPO antibodies are ordered primarily to investigate autoimmune thyroid disease, particularly Hashimoto thyroiditis, when patients present with hypothyroid symptoms (fatigue, weight gain, cold intolerance, hair loss, constipation) and a goiter on exam. The test helps distinguish autoimmune hypothyroidism from other causes, such as iodine deficiency or post-surgical hypothyroidism. In individuals with subclinical hypothyroidism (elevated TSH with normal free T4), a positive TPO antibody result markedly increases the likelihood of progression to overt hypothyroidism, about 4–5% per year compared to 1–2% without antibodies. Additionally, the test is part of the workup for unexplained infertility, recurrent miscarriage, and mood disturbances, as thyroid autoimmunity can affect fertility and pregnancy outcomes even with normal function.
The second common scenario is evaluating hyperthyroidism: while TSH receptor antibodies (TRAb) are the gold standard for Graves disease, TPO antibodies are positive in 50–80% of Graves cases, helping differentiate autoimmune from non-autoimmune thyrotoxicosis (e.g., subacute thyroiditis, toxic nodule). In pregnancy, TPO antibodies are checked because positivity, regardless of thyroid function, carries a two- to four-fold increased risk of miscarriage, preterm birth, and postpartum thyroiditis. Serial TSH monitoring every 4–6 weeks in pregnant antibody-positive women is recommended, and some guidelines advocate low-dose levothyroxine if TSH is >2.5 mIU/L. Thus, the doctor is trying to uncover an autoimmune process, gauge the risk of future thyroid dysfunction, and guide surveillance or early treatment.
What High TPO Antibodies Means
High TPO antibodies indicate autoimmune thyroid disease. Hashimoto thyroiditis: TPO antibodies are present in >90% of cases. The antibodies are a marker of autoimmune attack; TSH and free T4 determine current thyroid function. Many people have positive TPO antibodies with normal thyroid function; they are at increased risk of developing hypothyroidism (~2–4% per year) and should have TSH monitored periodically (e.g., annually). TPO antibodies are also positive in ~50–80% of Graves disease cases (though TSH receptor antibodies, TRAb, are the definitive Graves marker). TPO antibodies during pregnancy: positive antibodies, even with normal thyroid function, are associated with increased risk of miscarriage, preterm birth, and postpartum thyroiditis.
What Low TPO Antibodies Means
Low/negative TPO antibodies are normal. A negative test does not exclude non-autoimmune causes of thyroid dysfunction (iodine deficiency, drug-induced, post-surgical).
How to Prepare and What Affects the Result
Fasting is not required for TPO antibody measurement; however, the test is frequently drawn alongside a thyroid panel (TSH, free T4) that can be influenced by diurnal variation. TSH peaks in the early morning and drops by afternoon, so collecting samples in the morning provides consistent results. A critical interference is high-dose biotin (often >5 mg/day, found in hair/skin/nails supplements). Biotin interferes with streptavidin-biotin immunoassay platforms and can cause falsely low TPO antibody results. Patients should discontinue biotin for at least 48–72 hours before blood draw. Certain medications such as amiodarone, lithium, and interferon-alpha can induce or exacerbate thyroid autoimmunity, leading to a transient rise in TPO antibodies; clinicians should document these exposures. The sample type is serum (red-top or serum separator tube). Serum is stable at room temperature for up to 8 hours and refrigerated for 2 days; severe hemolysis may interfere with some assays. No special dietary restrictions are needed, but consistent timing of repeat testing aids interpretation.
Common Misinterpretations
One of the most frequent misinterpretations is equating a positive TPO antibody test with current thyroid dysfunction. TPO antibodies confirm autoimmune thyroid disease but provide no information about thyroid function; up to 20% of euthyroid individuals harbor positive antibodies, especially women and older adults. Misreading a positive result as meaning the patient is hypothyroid leads to inappropriate levothyroxine prescription without checking TSH and free T4. Another error involves low-level positivity (e.g., 35–100 IU/mL). Borderline titers are common and often transient; they can reflect nonspecific immune activation rather than progressive thyroiditis, yet they can trigger premature diagnosis and lifelong labeling with “Hashimoto disease.” Even among those with clear autoimmune thyroiditis, antibody levels do not correlate with disease severity or the need for treatment, so relying on titer trends rather than TSH to adjust therapy is a mistake.
Clinicians also commonly assume a positive TPO antibody exclusively indicates Hashimoto thyroiditis, overlooking its presence in about 50–80% of Graves disease patients. This mislabeling can delay appropriate management of hyperthyroidism. In pregnancy, a positive TPO antibody with a normal TSH is sometimes dismissed, despite evidence that it doubles the miscarriage risk and strongly predicts postpartum thyroiditis. The proper response is heightened surveillance, not to ignore the finding. Lastly, a negative TPO antibody result does not rule out autoimmune thyroid disease; approximately 10–15% of histologically confirmed Hashimoto patients are seronegative. In such cases, measuring thyroglobulin antibodies (TgAb) or performing thyroid ultrasound may be necessary when clinical suspicion remains high.
Frequently Asked Questions
What does a high TPO antibodies blood test mean?
A high TPO antibody level indicates that the immune system is attacking thyroid peroxidase, an enzyme needed for thyroid hormone production. It is the hallmark of autoimmune thyroid disease, present in over 90% of Hashimoto thyroiditis cases and in 50–80% of Graves disease. The result alone does not tell you if your thyroid is underactive or overactive; TSH and free T4 determine current thyroid function. Elevated antibodies increase the risk of future hypothyroidism by about 2–4% per year.
Can you have normal thyroid function with high TPO antibodies?
Yes, a significant number of people with positive TPO antibodies, up to 20–30% of the general population, have completely normal TSH and free T4 levels. This condition is called euthyroid autoimmune thyroiditis. While they have no thyroid dysfunction now, they are at increased risk of developing hypothyroidism over time, at roughly 2–4% annually. Regular TSH monitoring every 6–12 months is recommended, but treatment is not required unless TSH rises above the normal range.
How can I lower my TPO antibodies naturally?
There is no medication specifically approved to lower TPO antibodies. However, selenium supplementation (200 mcg/day for 3–6 months) has been shown in some studies to reduce antibody titers by 20–30% in patients with mild Hashimoto thyroiditis. Correcting severe vitamin D deficiency may also help, as low vitamin D is linked to higher antibodies. Gluten-free diets lack robust evidence for lowering antibodies in the absence of celiac disease. Always ensure thyroid hormone levels are optimized, as TSH elevation can drive further immune activation.
What is the difference between TPO antibodies and thyroglobulin antibodies?
Thyroid peroxidase (TPO) antibodies and thyroglobulin (Tg) antibodies target different thyroid proteins. TPO antibodies attack the enzyme that makes thyroid hormones, while Tg antibodies target thyroglobulin, the protein scaffold where hormone synthesis occurs. Both are present in most Hashimoto patients, but TPO antibodies are more prevalent and more strongly associated with thyroid dysfunction. Tg antibodies are often measured when TPO antibodies are negative but autoimmune thyroiditis is still suspected, or in monitoring thyroid cancer patients after treatment.
Do TPO antibodies affect pregnancy outcomes?
Yes, even when thyroid function is normal, positive TPO antibodies during pregnancy are linked to a two- to four-fold higher risk of miscarriage, preterm delivery, and postpartum thyroiditis. The antibodies can cross the placenta but typically do not harm the fetus directly; the risk likely stems from subtle thyroid insufficiency. Guidelines recommend checking TSH every 4–6 weeks in antibody-positive pregnant women, and some experts advocate low-dose levothyroxine if TSH is above 2.5 mIU/L to improve pregnancy outcomes.
Related Markers: Read Together for Full Context
BloodWorker reads lab values together, not in isolation. These related markers provide essential context for interpreting your TPO Antibodies result:
Upload Your Bloodwork for Cross-Referenced Analysis
BloodWorker reads all of your markers together , not one at a time , to surface the patterns a thoughtful clinician would notice. Upload your labs and see what the full picture reveals.
Get Started